Clinical significance of microvessel density in multiple myeloma patients

Journal of Korean Medical Science

Volumn 16, Issue 1, 2001, Pages 45-50

  Ahn, Myung Ju ^a   Park, Chan Kum ^a   Choi, Jung Hye ^a   Lee, Won Mee ^a   Lee, Young Yeul ^a   Choi, Il Young ^a   Kim, In Soon ^a   Lee, Woong Soo ^a   Ki, Moran ^b  

^a Hanyang University   (South Korea)

^b Eulji University   (South Korea)

Author keywords

Microvessel Density; Multiple Myeloma; Survival

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; VASCULOTROPIN; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; BONE MARROW; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; MICROCIRCULATION; MIDDLE AGED; MORTALITY; MULTIPLE MYELOMA; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY; SURVIVAL RATE; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW; ENDOTHELIAL GROWTH FACTORS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOKINES; MALE; MICROCIRCULATION; MIDDLE AGED; MULTIPLE MYELOMA; NEOVASCULARIZATION, PATHOLOGIC; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035259958     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2001.16.1.45     Document Type: Article

References (24)

1. Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on agniogenesis. N Engl J Med 1995; 333: 1757-63.
2. Folkman J. New perspectives in clinical oncology from angiogenesis research. Eur J Cancer 1996; 32(A): 2534-9.
3. Dickinson AJ, Fox SB, Persad RA, Hollyer J, Sibley GN, Harris AL. Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. Br J Urol 1994; 74: 762-6.
4. Fox SB. Tumor angiogenesis and prognosis. Histopathology 1997; 30: 294-301.
5. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
6. Nicosia RF, Tchao R, Leighton J. Interaction between newly formed endothelial channels and carcinoma cells in plasma clot culture. Clin Exp Metastasis 1986; 4: 91-104.
7. Hamada J, Cavanaugh PG, Lotan O, Nicholoson G. Separable growth and migration factors for large-cell lymphoma cells secreted by microvascular endothelial cells derived from target organs for metastasis. Br J Cancer 1992; 66: 349-54.
8. Rak J, Filmus J, Kerbel RS. Reciprocal paracrine interactions between tumor cells and endothelial cells; the angiogenesis progression hypothesis. Eur J Cancer 1996; 32(A): 2438-50.
9. Gasparini G, Weidner N, Maluta S, Pozza F, Boracchii P, Mezzetti M, Testolin A, Bevilacqua P. Intratumoral microvessel density and p53 protein; correlation with metastasis in head and neck squamous cell carcinoma. Int J Cancer 1993; 55: 739-44.
10. Ellis LM, Fidler IJ. Angiogenesis and breast cancer metastasis. Lancet 1995; 346: 388-90.
11. Maeda K, Chung YS, Takasuka S, Ogawa Y, Sawada T, Yamashita Y, Onoda N, Kato Y, Nitta A, Arimoto Y. Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol 1995; 13: 477-81.
12. Wiggins DL, Granai CO, Steinhoff MM, Calabresi P. Tumor angiogenesis as a prognostic factor in cervical carcinoma. Gynecol Oncol 1995; 56: 353-6.
13. Fontanini G, Lucchi M, Vignati S, Mussi A, Ciardiello F, De Laurentiis M, De Placido S, Basolo F, Angeletti CA, Bevilacqua G. Angiogenesis as a prognostic indicator of survival in non-small cell lung carcinoma: a prospective study. J Natl Cancer Inst 1997; 89: 8816.
14. Acenero MJ, Gonzalez JF, Gallego MG, Ballesteros PA. Vascular enumeration as a significant prognosticator for invasive breast carcinoma. J Clin Oncol 1998; 16: 1684-9.
15. Vacca A, Ribatti D, Roncali L, Dammacco F. Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies. Leuk Lymphoma 1995; 20: 27-38.
16. Perez-Atayde AR, Sallan SE, Tedrow U, Connors EA, Folkman J. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 1997; 150: 815-21.
17. Padro T, Ruiz S, Bieker R, Burger H, Steins M, Kienast J, Buchner T, Berdel WE, Mesters RM. Increased anigogenesis in the bone marrow of patients with acute myeloid leukemia. Blood 2000; 95: 2637-44.
18. Vacca A, Ribatti D, Roncali L, Ranieri G, Serio G, Silvestris F, Dammacco F. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 1994; 87: 503-8.
19. Durie BGM, Salmon SE. Multiple myeloma, macroglobulinemia, and monoclonal gammopathies. In: Hoffbrand AV, Brain MC, Hirsh J, eds. Recent Advances in Hematology. New York: Churchill Livingstone, 1977; 243.
20. Vermeulen PB, Gasparini G, Fox SB, Toi M, Martin L, McCulloch P, Pezzella F, Viale G, Weidner N, Harris AL, Dirix LY. Quantification of angiogenesis in solid human tumors: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 1996; 32(A): 2474-84.
21. Dankbar B, Padro T, Leo R, Felmann B, Kropff M, Mesters RM, Serve H, Berdel WE, Kienast J. Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma. Blood 2000; 95: 2630-6.
22. Rajkumar SV, Fonseca R, Witzig TE, Gertz MA, Geipp PR. Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma. Leukemia 1999; 13: 469-72.
23. Vacca A, Ribatti D, Presta M, Minischetti M, Lurlaro M, Ria R, Albini A, Bussolino F, Dammacco F. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood 1999; 93: 3064-73.
24. Barille A, Akhoundi C, Collette M, Mellerin MP, Rapp MJ, Haroussean JL, Bataille R, Amiot M. Metalloproteinases in multiple myeloma. Production of matrix metalloproteinase-9, activation of proMMP-2, and induction of MMP-1 by myeloma cells. Blood 1997; 90: 1649-55.